<code id='7A46F3A832'></code><style id='7A46F3A832'></style>
    • <acronym id='7A46F3A832'></acronym>
      <center id='7A46F3A832'><center id='7A46F3A832'><tfoot id='7A46F3A832'></tfoot></center><abbr id='7A46F3A832'><dir id='7A46F3A832'><tfoot id='7A46F3A832'></tfoot><noframes id='7A46F3A832'>

    • <optgroup id='7A46F3A832'><strike id='7A46F3A832'><sup id='7A46F3A832'></sup></strike><code id='7A46F3A832'></code></optgroup>
        1. <b id='7A46F3A832'><label id='7A46F3A832'><select id='7A46F3A832'><dt id='7A46F3A832'><span id='7A46F3A832'></span></dt></select></label></b><u id='7A46F3A832'></u>
          <i id='7A46F3A832'><strike id='7A46F3A832'><tt id='7A46F3A832'><pre id='7A46F3A832'></pre></tt></strike></i>

          explore

          explore

          author:fashion    Page View:3552
          UnitedHealth Group
          UnitedHealth Group’s Optum will pay $3.3 billion total for the home health giant Amedisys. Jim Mone/AP

          Home health and hospice chain Amedisys has chosen a new corporate owner.

          Amedisys and UnitedHealth Group’s Optum agreed to a deal Monday in which UnitedHealth will pay $101 per share in cash for Amedisys, totaling $3.3 billion. UnitedHealth’s latest offer is $1 per share higher than what it proposed in its unsolicited buyout offer a few weeks ago.

          advertisement

          Option Care Health, a company that delivers intravenous medicines and mails health care supplies to people’s homes, originally offered to acquire Amedisys in May in an all-stock deal. However, the attractiveness of that deal deteriorated after Option Care’s stock price plummeted soon after the company made its bid.

          Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

          GET STARTED Log In

          explore

          Medicare proposal to cover medical devices draws a mixed reaction
          Medicare proposal to cover medical devices draws a mixed reaction

          AdobeThemedicaldeviceindustryissplitonwhetheraproposednewMedicarereimbursementpathwaywilldoanythingt

          read more
          AstraZeneca, Daiichi breast cancer treatment succeeds in trial
          AstraZeneca, Daiichi breast cancer treatment succeeds in trial

          AlastairGrant/APLONDON—AstraZenecasaidFridayanexperimentaldrugtampeddowntheprogressionofacertaintype

          read more
          ChatGPT in medicine: STAT answers readers' burning questions
          ChatGPT in medicine: STAT answers readers' burning questions

          MikeReddyforSTATArtificialintelligenceisoftendescribedasablackbox:anunknowable,mysteriousforcethatop

          read more

          Medical student insurance fails on mental health care coverage

          OLIVIERDOULIERY/AFPviaGettyImagesMedicalstudentsexperiencesignificantmentaldistress,includinghighrat